IMB Centre for Superbug Solutions

IMB researchers are sharing their expertise in tackling drug-resistant bacteria with low and middle income countries, thanks to new funding from CARB-X.

The main non-psychoactive component of cannabis has been shown to kill the bacteria responsible for gonorrhoea, meningitis and Legionnaires' disease.

Tackling antibiotic resistance and exploring the role of genomics in the novel coronavirus are the focus of new funding from the NHMRC, to fight infectious disease.

Researchers are using tiny fluorescent probes to investigate how and why bacteria are becoming resistant to antibiotics.

Droplets of fat inside our cells are helping us fight back against infection.

IMB researchers have investigated a peptide from the marine sandworm, which has the power to kill superbugs.

A new antibiotic, Octapeptin-X that targets the most dangerous drug-resistant bacteria has been given a funding boost by CARB-X.

Bacteria and viruses are all around us - some beneficial and some fatal.

Ian Henderson, Professor of Microbiology, and Dr Larisa Labzin, Virologist, discuss COVID-19 – immunity, vaccine development, epidemiology and what we do and don’t know.

Compounds containing metals could hold the key to the next generation of antibiotics to combat the growing threat of global antibiotic resistance.